← Back to Company DatabaseVisit Website
Illumina
Next-generation sequencing technology powering cancer genomics worldwide.
PublicSan Diego, CAFounded 1998
About
Illumina is the global leader in DNA sequencing technology, providing the instruments and reagents that underpin much of modern cancer genomics. Its platforms are used for tumor profiling, liquid biopsy development, and large-scale cancer research worldwide. The company's TruSight Oncology 500 panel enables comprehensive genomic profiling of solid tumors.
Total Funding
UndisclosedKey Product
NovaSeq sequencing system and TruSight Oncology panelsGeography
North AmericaKey Investors
Public market investors
Focus Areas
DiagnosticsData / Analytics
Technology
Genomics / Sequencing
Cancer Types
Pan-cancer
Last updated: Feb 4, 2026